|
OMMH
|
Omnimmune Holdings Inc
|
US
|
OTC
|
|
ONCO
|
Oncopeptides AB
|
SE
|
ST
|
|
ONCS
|
OncoSec Medical Incorporated
|
US
|
NASDAQ
|
|
ONCY
|
Oncolytics Biotech Inc.
|
US
|
NASDAQ
|
|
ONVO
|
Organovo Holdings, Inc.
|
US
|
NASDAQ
|
|
ONWD
|
Onward Medical N.V.
|
BE
|
BR
|
|
OPGN
|
OpGen, Inc.
|
US
|
NASDAQ
|
|
OPK
|
OPKO Health Inc.
|
US
|
NASDAQ
|
|
OPT
|
Opthea Ltd
|
AU
|
ASX
|
|
OPT
|
Opthea Limited
|
US
|
NASDAQ
|
|
ORGO
|
Organogenesis Holdings Inc.
|
US
|
NASDAQ
|
|
ORGS
|
Orgenesis Inc.
|
US
|
NASDAQ
|
|
ORPHA
|
Orphazyme A/S
|
DK
|
CO
|
|
ORTX
|
Orchard Therapeutics plc
|
US
|
NASDAQ
|
|
ORY
|
Oryzon Genomics SA
|
ES
|
MC
|
|
OSE
|
OSE Pharma SA
|
FR
|
PA
|
|
OSTX
|
OS Therapies Incorporated
|
US
|
US
|
|
OTLK
|
Outlook Therapeutics, Inc.
|
US
|
NASDAQ
|
|
OVID
|
Ovid Therapeutics Inc.
|
US
|
NASDAQ
|
|
OVIT
|
Oncovista Innovative Therapies I
|
US
|
OTC
|